These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27519492)

  • 21. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease.
    Imbimbo BP; Troetel WM; Martelli P; Lucchelli F
    Dement Geriatr Cogn Disord; 2000; 11(1):17-24. PubMed ID: 10629357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E; Recalcati P; Tantalo V; Bregnani P
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of vincamine in dementia.
    Fischhof PK; Möslinger-Gehmayr R; Herrmann WM; Friedmann A; Russmann DL
    Neuropsychobiology; 1996; 34(1):29-35. PubMed ID: 8884757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic use of nicergoline.
    Winblad B; Fioravanti M; Dolezal T; Logina I; Milanov IG; Popescu DC; Solomon A
    Clin Drug Investig; 2008; 28(9):533-52. PubMed ID: 18666801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.
    Hanus M; Lafon J; Mathieu M
    Curr Med Res Opin; 2004 Jan; 20(1):63-71. PubMed ID: 14741074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of xantinolnicotinate in patients with dementia.
    Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
    Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial.
    Ikeda M; Mori E; Matsuo K; Nakagawa M; Kosaka K
    Alzheimers Res Ther; 2015; 7(1):4. PubMed ID: 25713599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.
    Emre M; Tsolaki M; Bonuccelli U; Destée A; Tolosa E; Kutzelnigg A; Ceballos-Baumann A; Zdravkovic S; Bladström A; Jones R;
    Lancet Neurol; 2010 Oct; 9(10):969-77. PubMed ID: 20729148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial.
    Jia J; Wei C; Liang J; Zhou A; Zuo X; Song H; Wu L; Chen X; Chen S; Zhang J; Wu J; Wang K; Chu L; Peng D; Lv P; Guo H; Niu X; Chen Y; Dong W; Han X; Fang B; Peng M; Li D; Jia Q; Huang L
    Alzheimers Dement; 2016 Feb; 12(2):89-99. PubMed ID: 26086183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S
    EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled study of nicergoline in the treatment of pruritus in patients receiving maintenance hemodialysis.
    Bousquet J; Rivory JP; Maheut M; Michel FB; Mion C
    J Allergy Clin Immunol; 1989 Apr; 83(4):825-8. PubMed ID: 2708742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial.
    Gruenwald J; Graubaum HJ; Busch R
    Arzneimittelforschung; 2005; 55(11):669-76. PubMed ID: 16366041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idebenone in the treatment of multi-infarct dementia: a randomised, double-blind, placebo controlled multicentre trial.
    Bergamasco B; Villardita C; Coppi R
    Arch Gerontol Geriatr; 1992; 15(3):271-8. PubMed ID: 15374366
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.